Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14817 | 679 | 46.1 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
313 | 17635 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SYK | Author keyword | 38 | 31% | 15% | 103 |
2 | SPLEEN TYROSINE KINASE | Author keyword | 22 | 55% | 4% | 28 |
3 | R788 | Author keyword | 12 | 86% | 1% | 6 |
4 | SPLEEN TYROSINE KINASE SYK | Author keyword | 9 | 55% | 2% | 12 |
5 | R406 | Author keyword | 9 | 67% | 1% | 8 |
6 | FOSTAMATINIB | Author keyword | 8 | 48% | 2% | 12 |
7 | ZAP 70 | Author keyword | 6 | 15% | 5% | 37 |
8 | SYK KINASE | Author keyword | 5 | 28% | 2% | 14 |
9 | SYK INHIBITOR | Author keyword | 4 | 67% | 1% | 4 |
10 | RAST SECT | Address | 3 | 57% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SYK | 38 | 31% | 15% | 103 | Search SYK | Search SYK |
2 | SPLEEN TYROSINE KINASE | 22 | 55% | 4% | 28 | Search SPLEEN+TYROSINE+KINASE | Search SPLEEN+TYROSINE+KINASE |
3 | R788 | 12 | 86% | 1% | 6 | Search R788 | Search R788 |
4 | SPLEEN TYROSINE KINASE SYK | 9 | 55% | 2% | 12 | Search SPLEEN+TYROSINE+KINASE+SYK | Search SPLEEN+TYROSINE+KINASE+SYK |
5 | R406 | 9 | 67% | 1% | 8 | Search R406 | Search R406 |
6 | FOSTAMATINIB | 8 | 48% | 2% | 12 | Search FOSTAMATINIB | Search FOSTAMATINIB |
7 | ZAP 70 | 6 | 15% | 5% | 37 | Search ZAP+70 | Search ZAP+70 |
8 | SYK KINASE | 5 | 28% | 2% | 14 | Search SYK+KINASE | Search SYK+KINASE |
9 | SYK INHIBITOR | 4 | 67% | 1% | 4 | Search SYK+INHIBITOR | Search SYK+INHIBITOR |
10 | SYK INHIBITORS | 3 | 50% | 1% | 4 | Search SYK+INHIBITORS | Search SYK+INHIBITORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | P72SYK | 20 | 48% | 4% | 30 |
2 | INTERDOMAIN B | 17 | 100% | 1% | 8 |
3 | SPLEEN TYROSINE KINASE | 14 | 33% | 5% | 36 |
4 | R406 | 14 | 100% | 1% | 7 |
5 | SYK | 13 | 16% | 11% | 74 |
6 | ZAP 70 KINASE | 11 | 46% | 3% | 18 |
7 | TYROSINE KINASE SYK | 11 | 28% | 5% | 33 |
8 | ZAP 70 | 10 | 15% | 9% | 60 |
9 | PHOSPHORYLATED ITAM PEPTIDE | 10 | 63% | 1% | 10 |
10 | SYK KINASE | 9 | 38% | 3% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The SYK tyrosine kinase: a crucial player in diverse biological functions | 2010 | 282 | 185 | 38% |
The structure, regulation, and function of ZAP-70 | 2009 | 76 | 75 | 57% |
Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer | 2015 | 1 | 111 | 50% |
Tyrosine kinase SYK: essential functions for immunoreceptor signalling | 2000 | 231 | 53 | 53% |
Spleen tyrosine kinase inhibitors: a review of the patent literature 2010-2013 | 2014 | 3 | 25 | 84% |
Getting Syk: spleen tyrosine kinase as a therapeutic target | 2014 | 5 | 103 | 56% |
Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations? | 2014 | 3 | 41 | 71% |
Spleen tyrosine kinases: biology, therapeutic targets and drugs | 2010 | 43 | 65 | 57% |
The Syk family of protein tyrosine kinases in T-cell activation and development | 1998 | 178 | 77 | 56% |
Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases | 2014 | 14 | 92 | 20% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RAST SECT | 3 | 57% | 0.6% | 4 |
2 | MED EXPT EDUC | 2 | 67% | 0.3% | 2 |
3 | MOL ONCOL DRUG DISCOVERY PROGRAM | 2 | 36% | 0.6% | 4 |
4 | JONATHAN JAQUES CANC | 1 | 50% | 0.3% | 2 |
5 | CARDIOVASC PHYSIOL PATHOPHYSIOL | 1 | 33% | 0.4% | 3 |
6 | INFLAMMAT DISCOVERY THER EUT AREA | 1 | 33% | 0.4% | 3 |
7 | RECEPTORS SIGNAL TRANSDUCT SECT | 1 | 18% | 0.7% | 5 |
8 | PROTEOMCHUO KU | 1 | 27% | 0.4% | 3 |
9 | MTA SE LENDULET INFLAMMAT PHYSIOL GRP | 1 | 33% | 0.3% | 2 |
10 | CNRSINSERMU661 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000232138 | SLP 76//LINKER FOR ACTIVATION OF T CELLS//SECT LYMPHOCYTE SIGNALING |
2 | 0.0000178867 | CELLULAR INJURY//TCR ZETA CHAIN//CD3 GAMMA |
3 | 0.0000154740 | VAV//VAV1//VAV3 |
4 | 0.0000145321 | CBL B//CBL//CIN85 |
5 | 0.0000134714 | CD45//CD45 ISOFORMS//P56LCK |
6 | 0.0000130816 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
7 | 0.0000103447 | SURFACE IGM//IG ALPHA//MEMBRANE IMMUNOGLOBULIN |
8 | 0.0000085739 | TOFACITINIB//JAK3//CP 690 550 |
9 | 0.0000085405 | GRB2//SH2 DOMAIN//SH3 DOMAIN |
10 | 0.0000080688 | NEUTROPHIL SIGNALLING GRP//MOL SIGNALLING GRP//FFP 18 |